MENU
+Compare
BYSI
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$2.10
Change
-$0.01 (-0.47%)
Capitalization
86.31M

BYSI BeyondSpring Forecast, Technical & Fundamental Analysis

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies... Show more

BYSI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BYSI with price predictions
Nov 12, 2025

BYSI in upward trend: price rose above 50-day moving average on October 21, 2025

BYSI moved above its 50-day moving average on October 21, 2025 date and that indicates a change from a downward trend to an upward trend. In of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 10, 2025. You may want to consider a long position or call options on BYSI as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BYSI just turned positive on November 11, 2025. Looking at past instances where BYSI's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for BYSI crossed bullishly above the 50-day moving average on October 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for BYSI moved above the 200-day moving average on November 12, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BYSI advanced for three days, in of 235 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BYSI moved out of overbought territory on October 22, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 44 cases where BYSI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BYSI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BYSI broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BYSI entered a downward trend on October 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BYSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (31.056) is also within normal values, averaging (322.723).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BYSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BYSI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of cancer therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
28 Liberty Street
Phone
+1 646 305-6387
Employees
67
Web
https://www.beyondspringpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLVLY7.180.03
+0.42%
Clinuvel Pharmaceuticals Ltd.
PZAKY19.24N/A
N/A
Powszechny Zaklad Ubezpieczen SA
KOJAF12.30N/A
N/A
Kojamo PLC
CISCF0.02N/A
N/A
CISCOM CORP.
ROKRF0.16N/A
-1.11%
ROK Resources Inc.

BYSI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with GOSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
-3.64%
GOSS - BYSI
38%
Loosely correlated
+4.25%
CYTK - BYSI
37%
Loosely correlated
-0.84%
VNDA - BYSI
33%
Poorly correlated
+0.68%
APGE - BYSI
32%
Poorly correlated
+0.24%
TAOX - BYSI
31%
Poorly correlated
-1.75%
More